Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

@article{Carella2000AutograftingFB,
  title={Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.},
  author={Angelo Michele Carella and Mara Cavaliere and Enrica Lerma and Roberto Ferrara and Lucilla Tedeschi and A. Romanelli and Maria Vinci and Graziella Pinotti and Paola Lambelet and C. Loni and Simonetta Verdiani and Fabio De Stefano and Mauro Valbonesi and Maria Teresa Corsetti},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2000},
  volume={18 23},
  pages={
          3918-24
        }
}
PURPOSE To investigate the use of a nonmyeloablative fludarabine-based immunosuppressive regimen to allow engraftment of HLA-sibling donors' mobilized stem cells and induction of a graft-versus-lymphoma effect for patients with advanced resistant Hodgkin's disease and non-Hodgkin's lymphoma. PATIENTS AND METHODS Fifteen patients with Hodgkin's disease (n = 10) and non-Hodgkin's lymphoma (n = 5) were studied. All patients received cyclophosphamide and granulocyte colony-stimulating factor to… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 84 CITATIONS, ESTIMATED 57% COVERAGE

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma

Jacopo Mariotti, Stefania Bramanti, +15 authors Luca Castagna
  • Bone Marrow Transplantation
  • 2017
VIEW 2 EXCERPTS
CITES METHODS & RESULTS

FILTER CITATIONS BY YEAR

2001
2019

CITATION STATISTICS

  • 3 Highly Influenced Citations